Stock News

Get the Scoop: Aion Therapeutic’s BiWeekly MCTO Status Update is Here! Toronto, Ontario–(Newsfile Corp. – September 26, 2024) – Aion Therapeutic Inc. (CSE: AION) – “Aion Therapeutic” or the “Company” Aion Therapeutic is providing this bi-weekly update on the status of its management cease trade order issued on August 29, 2024 (the “MCTO”), by its…

Welcome to the Blog Post on Alerus Financial Corporation’s Acquisition of HMN Financial Inc. Exciting News in the Financial Sector GRAND FORKS, N.D. and ROCHESTER, Minn., Sept. 26, 2024 (GLOBE NEWSWIRE) — Alerus Financial Corporation (Nasdaq: ALRS) and its wholly owned subsidiary, Alerus Financial, National Association, (together, “Alerus”) announced today they have received all regulatory…

Premium Catering (Holdings) Limited Closes Initial Public Offering SINGAPORE, Sept. 26, 2024 (GLOBE NEWSWIRE) — Premium Catering (Holdings) Limited (“PC” or the “Company”), a leading food caterer supplying prepared meals to foreign workers in Singapore, as well as operating food stalls and providing buffet catering services, has successfully closed its initial public offering. The Offering…

Cue Biopharma Commences Public Offering: A Breakthrough in Therapeutic Biologics What is Cue Biopharma? Cue Biopharma, Inc. (Nasdaq: CUE) is a cutting-edge clinical-stage biopharmaceutical company based in Boston. With a focus on developing a new class of therapeutic biologics, Cue Biopharma aims to selectively engage and modulate disease-specific T cells. Their innovative approach has garnered…

Welcome to the World of Stockholder Meetings! Postponed Meeting, Same Excitement Hey there fellow stockholders! Have you heard the news about the special meeting of Hennessy Capital Investment Corp. VI being postponed? Yes, you read that right. The meeting that was supposed to happen on September 27, 2024, has been rescheduled to September 30, 2024….

Exciting News in the World of Diagnostic Testing! The Introduction of a Groundbreaking Product Line Have you heard the news? QIAGEN, a global leader in molecular diagnostics, has recently announced that their product line, which includes the QIAstat-Dx Analyzer, QIAstat-Dx Rise, and panels for the detection of gastrointestinal and respiratory infections, has earned the prestigious…

The Future of Medicine: NurExone Biologic Inc. Announces Private Placement Offering TORONTO and HAIFA, Israel, Sept. 26, 2024 NurExone Biologic Inc. is making waves in the biopharmaceutical industry with their cutting-edge exosome-based therapies. With the announcement of a non-brokered private placement offering, the company is positioning itself for further growth and innovation. The Offering, totaling…

Riverview Bancorp, Inc. Announces Stock Repurchase Program Riverview Bancorp, Inc. Vancouver, Wash., Sept. 26, 2024 (GLOBE NEWSWIRE) Riverview Bancorp, Inc. (Nasdaq GSM: RVSB) (“Riverview” or the “Company”) headquartered in Vancouver, WA, the holding company parent of Riverview Bank, announced that on September 25, 2024, its Board of Directors adopted a stock repurchase program. Under this…